Login to Your Account

Financings Roundup

Apoptos Targeting Cell Death with $28M Series A Financing

By Jennifer Boggs

Wednesday, May 7, 2008
Year-old Apoptos Inc. is raising $28 million in its first major funding round since being established in June 2007 by venture firms Venrock and ARCH Ventures based on technology targeting programmed cell death. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription